Randomized Trialhigh evidence
Personalized Blood Pressure Targeting After Endovascular Therapy for Acute Ischemic Stroke: A Randomized Clinical Trial.
JAMA neurology·June 8, 2026·PMID 42258192
Why it mattersThis trial provides evidence that blood pressure targets after thrombectomy should be individualized based on reperfusion quality, challenging the one-size-fits-all approach. It offers a practical strategy to improve functional recovery and reduce hemorrhagic transformation without increasing harm.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled